Top Markets
#1 DeFiChain DeFiChain +1,198.24%
#2 Superfortune Superfortune +102.78%
#3 V.I.T.R.I.O.L. Network V.I.T.R.I.O.L. Network +82.96%
#4 The Black Bull The Black Bull +80.59%
#5 Metaplex Metaplex +79.35%
#6 TokenOS AI TokenOS AI +59.62%
#7 Nexus Nexus +56.52%
#8 Alien Worlds Alien Worlds +55.53%
#9 Magma Finance Magma Finance +47.14%
#10 Hamster Kombat Hamster Kombat +36.70%
Coin of the day
DeFiChain DeFiChain
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Virbac SA Virbac SA

Virbac SA

VIRP
Clasificación en acciones #3592
Virbac SA manufactures and sells a range of products and services for companion... Virbac SA manufactures and sells a range of products and services for companion and food-producing animals in France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.
Precio por acción
$393.80
Capitalización bursátil
$3.30B
Cambio (1 día)
0.15%
Cambio (1 año)
4.67%
País
FR
Comercio Virbac SA (VIRP)

Categoría

Healthcare
Ratio P/S de Virbac SA (VIRP)
Ratio P/S al July 2026 TTM: 1.90
Según los informes financieros más recientes y el precio de las acciones de Virbac SA, el ratio P/S actual (TTM) es 1.90. Al final de 2023, el ratio P/S era 2.39.
Historial del ratio P/S de Virbac SA desde 2002 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
2026 (TTM) 1.90 0.10%
2024 1.90 -20.75%
2023 2.39 51.21%
2022 1.58 -53.01%
2021 3.37 56.81%
2020 2.15 1.14%
2019 2.13 92.67%
2018 1.10 -8.14%
2017 1.20 -25.72%
2016 1.62 -25.62%
2015 2.17 14.35%
2014 1.90 6.88%
2013 1.78 -2.04%
2012 1.82 12.05%
2011 1.62 -17.65%
2010 1.97 45.76%
2009 1.35 19.90%
2008 1.13 -16.59%
2007 1.35 33.26%
2006 1.01 11.69%
2005 0.91 46.87%
2004 0.62 -14.23%
2003 0.72 7.76%
2002 0.67 0.00%
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
Eli Lilly Eli Lilly
Eli Lilly
LLY.US
15.63 721.94%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
6.34 233.58%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
7.07 271.80%
US
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
4.84 154.22%
US
Novartis AG Novartis AG
Novartis AG
NVS.US
5.38 182.92%
CH